New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection.
about
Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's diseaseMelatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.Potassium 2-(l-hydroxypentyl)-benzoate attenuates neuroinflammatory responses and upregulates heme oxygenase-1 in systemic lipopolysaccharide-induced inflammation in mice.Ameliorative effect of melatonin against increased intestinal permeability in diabetic rats: possible involvement of MLCK-dependent MLC phosphorylation.
P2860
New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
New melatonin-cinnamate hybrid ...... nt effect and neuroprotection.
@en
type
label
New melatonin-cinnamate hybrid ...... nt effect and neuroprotection.
@en
prefLabel
New melatonin-cinnamate hybrid ...... nt effect and neuroprotection.
@en
P2093
P2860
P50
P356
P1476
New melatonin-cinnamate hybrid ...... ant effect and neuroprotection
@en
P2093
Alicia López
Elisa Navarro
Isabel Gameiro
Manuela G López
P2860
P304
P356
10.4155/FMC.15.99
P577
2015-10-23T00:00:00Z